ProductUpdated on 9 February 2025
sustainable & standardized human biomaterials
About
THT Biomaterials GmbH was founded in 2020, to isolate multiple sustainable and standardized human biomaterials from placenta batches, to replace animal-derived biomaterials in a broad spectrum of applications, to speed up and de-risk many medical translation processes.
Human placenta is collected after informed consent and serological testings.
Our first products are:
Collagen type-I
Collagen type-IV
Laminin type-111
HUMAN PLACENTA Substrate
HUMAN PLACENTA ECM
(more products pending)
Our first applications are:
defined 2D coatings
3D gels/tissue ink
organoids
Lab-on-chips
barrier models
membranes
filler
(more applications pending)
Contact us
Applies to
- Life Science, Healthcare & Cosmetics
Organisation
Similar opportunities
Product
Johannes Hackethal
CEO, founder at THT Biomaterials GmbH
Vienna, Austria
Product
Bio-leather and textiles made from local organic waste
- Waste Cycle
- Circular Economy
- Textiles And Fashion
Dario Cottafava
Assistant Professor and Cofounder at Reconversion Circular
Barcelona, Spain
Project cooperation
Valdemar Ehlers
Technical Director at Danish Maritime
Copenhagen, Denmark